Nektar Therapeutics
NKTR
#4613
Rank
HK$19.36 B
Marketcap
HK$573.27
Share price
0.45%
Change (1 day)
223.73%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2026 (TTM): -HK$65.82

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$66.04. In 2025 the company made an earnings per share (EPS) of -HK$80.00 a decrease over its 2024 EPS that were of -HK$69.49.

EPS history for Nektar Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$65.82-17.72%
2025-HK$80.0015.12%
2024-HK$69.49-59.54%
2023-HK$171.77-25.89%
2022-HK$231.77-31.12%
2021-HK$336.4814.86%
2020-HK$292.95-1.19%
2019-HK$296.48-163.96%
2018HK$463.54-725.4%
2017-HK$74.12-42.73%
2016-HK$129.4283.33%
2015-HK$70.5939.53%
2014-HK$50.59-69.29%
2013-HK$164.71-6.67%
2012-HK$176.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.51-203.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.27-115.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.57-271.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$16.71-74.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$28.04-142.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.51-182.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
HK$2.12-103.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$7.29-111.05%๐Ÿ‡ฎ๐Ÿ‡ช Ireland